Cervical cancer

Overcoming challenges and achieving high HPV vaccination uptake in Cameroon: lessons learned from a gender-neutral and single-dose program and community engagement | BMC Public Health

by

This study highlights the implementation process and major interventions used to improve coverage. Organization of HPV vaccine introduction HPV vaccination was introduced through routine immunization in 2020 in all vaccination health facilities and selected schools. The first phase involved a cascade training of health and communication stakeholders at all the health pyramid levels. This step … Read more

Denmark on track to eradicate cervical cancer by 2040 — a global first, study says

by

COPENHAGEN, April 15 — Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening programme, the Danish Cancer Society said on Monday. “Even before 2040, so few women may have the disease that it may be considered eradicated,” the Danish Cancer Society said in a statement. “It would … Read more

My ‘classic’ cancer symptoms were dismissed as an STI for a year – now I’m in constant pain and can’t care for my kids

by

STEPH Washington was diagnosed with terminal cancer following a year long delay after bungling medics dismissed her symptoms as a STI. The 38-year-old mum-of-three has was left in constant pain with “classic” cervical cancer symptoms – but says she was never offered a smear test and was “repeatedly failed” by the NHS and her GP … Read more

New study connects parasitic disease to genetic changes in the cervical lining

by

New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment. Presented today at ESCMID Global 2025, this pivotal study sheds new light on how this often-overlooked parasitic disease may contribute to cervical cancer risk … Read more

Exploring the role of cervicovaginal microbiota as risk factor for cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis | BMC Women’s Health

by

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. Epub 2021 Feb 4. Article  PubMed  Google Scholar  De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, … Read more

OICR funds five innovative cancer drug discovery projects

by

The Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause fewer side effects and reduce the risk that cancer will come back. The projects will be funded as part of OICR’s Cancer Therapeutics Innovation Pipeline … Read more

At-home DIY cervical cancer screening test could be rolled out ‘early 2026’, NHS says

by

AT- HOME cervical screening tests could be rolled out in England from as early as next year, health chiefs have announced. The move could “revolutionise access” to screening and help eliminate cervical cancer by 2040, according to NHS England chief executive Amanda Pritchard. 2 At-home cervical cancer tests could be rolled out next year to … Read more

Adjuvant Chemo vs Radiotherapy Alone in Cervical Cancer

by

New findings on radiation plus adjuvant chemotherapy in patients with intermediate-risk cervical cancer seem to spell the end for the dual therapy in this group.  Results from a phase 3 clinical trial of 316 women who’d had radical hysterectomies found that adjuvant chemotherapy as treatment for their early-stage, intermediate-risk cervical carcinoma did not improve outcomes … Read more

HPV Vaccine Succeeds Against Cervical Precancers

by

Incidence of preliminary cervical cancer decreased by approximately 80% among women aged 20-24 years in the United States since the widespread use of the human papillomavirus (HPV) vaccine, according to new data from the Centers for Disease Control and Prevention (CDC). The HPV vaccine was first recommended in 2006 for the prevention of cancers and … Read more

Gaps in HPV cancer screening and prevention identified for people living with HIV

by

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities. A literature review, conducted by a team of international experts underscores the need for further research and highlights existing disparities in healthcare for this vulnerable population. HPV-related … Read more